We analyzed its mRNA degree of expression in 26 tumor tissues and 17 normal tissues by qRT-PCR, we found that RPS6KA2 mRNA levels were significantly lower in ovarian cancer patient tissues compared to those in normal tissues (Figure 1E). This evidence concerns the gene RPS6KA2 and ovarian carcinoma.